Recorded lectures

Tutors

• Ms Jenny Kirkwood
  
• Ms Mary McBride
  Pharmacy Advisor, SPPG
• Ms Clare Stevenson
  Speech and Language Therapist and Dysphagia Coordinator SEHSCT

Aim

To provide an overview of best practice in assessing dysphagia in adult patients including the implementation of the IDSSI descriptors and how they relate to medication options This programme will be delivered over two evenings. Part 2 will be held on Wednesday 28th September and Thursday 20th October.

Learning outcomes

Intended learning outcomes:

• Regional update on the work of Dysphagia NI
• Identify eating, drinking and swallowing difficulties
• Assess patients with swallowing difficulties, decide when Speech and Language therapy should be involved, and on whose advice should medications be changed from solid dosage forms
• Outline IDDSI descriptors and how thickeners may be used within different descriptor levels
• Utilise a stepwise approach to medication selection for patients with eating, drinking and swallowing difficulties, whilst signposting to resources to assist with this.

Tutors

• Ms Clare Stevenson
  Speech and Language Therapist and Dysphagia Coordinator SEHSCT
• Ms Mary McBride
  Pharmacy Advisor, SPPG
• Ms Carolee McLaughlin
  

Aim

To provide an overview of the DAMES project, as an example of a Quality Improvement project, accompanied by reflection and discussion of learnings from previous Serious Adverse Incidents to reduce the risk of further choking events, through multidisciplinary collaborative working.

Learning outcomes

Intended learning outcomes:

• Provide an overview of Dames, as an example of quality improvement projects supporting medication use for people with eating, drinking, swallowing difficulties
• Utilise learnings from local serious adverse incidents to reduce patient harm
• Multidisciplinary discussion regarding reducing the risk of further choking events through improved communication pathways.

Tutors

• Mrs Aine Liggett
  Northern Ireland Medicines and Poisons Advice Service
• Ms Siobhan Kelly
  Lead Nurse for Yellow Card Centre Northern Ireland

Aim

To promote the importance of healthcare professionals reporting adverse events to the MHRA’s Yellow Card scheme to improve patient safety.

Learning outcomes

Having completed this webinar you will be able to:

• Describe the role of the NI Yellow Card Centre
• Understand the benefits of reporting via the Yellow Card scheme
• List the range of products for which safety issues should be reported
• Define the information to be reported within a Yellow Card report
• Report relevant adverse events within your professional practice.

Tutors

• Ms Lisa Byers
  Controlled Drugs DoH (CDAO)
• Ms Joy Watson
  Addictions Consultant, BHSCT
• Mr Canice Ward
  Head of Medicines Regulatory Group, Department of Health
• Dr Carolyn Adgey
  Consultant Gastroenterologist, BHSCT

Aim

To provide a discussion forum to explore the potential misuse of OTC opioid products. Specifically, to recognise the signs and symptoms of their misuse, discuss and explore strategies to manage the supply of these medicines in the community pharmacy setting and provide support to patients who have developed problems with these products.

Learning outcomes

Having completed this webinar, you will be able to:

• Define the terms misuse and dependence
• Recognise signs of opioid misuse and dependence
• Consider strategies to help prevent/reduce the abuse of opioid products in a community pharmacy setting
• Discuss the risks of potential misuse/dependence with patients
• Share your knowledge with your pharmacy team to ensure safe and effective supply of OTC opioid products.

Tutors

• Ms Nicola Burchmore
  Community Infant Feeding Lead, WHSCT
• Ms Claire Guy
  Specialist Paediatric Dietitian, WHSCT
• Ms Emma McCammon
  Pharmacy Adviser, SPPG
• Ms Maria Somers
  Maria Somers – Health Visitor, WHSCT
• Ms Emma Willox
  Health Visitor, WHSCT

Aim

To provide an update on the best practice for the management of Cows Milk Allergy (CMA).

Learning outcomes

Having completed this webinar, you will be able to:

• Recognise normal newborn behaviour and identify the signs and symptoms of CMA
• Recommend appropriate treatment options based on current evidence based guidance
• Understand the importance of ongoing review with a view to deprescribing where appropriate
• Provide comprehensive advice, support and reassurance to parents and carers regarding the management of children with CMA
• Refer appropriately and seek advice from dietetics when managing children with CMA.